Upadacitinib Hemihydrate: A Comprehensive Overview
Upadacitinib hemihydrate (CAS 2050057-56-0) is a significant chemical compound that has gained considerable attention in the pharmaceutical and related industries. This article aims to provide a detailed introduction to Upadacitinib hemihydrate, covering its properties, uses, applications in various fields, and preparation methods.
I. Product Introduction
Upadacitinib hemihydrate is a specific form of Upadacitinib. Upadacitinib itself is a Janus kinase (JAK) inhibitor. The hemihydrate form indicates that it contains half a molecule of water per molecule of the active compound. This form may have unique physical and chemical properties compared to the anhydrous form or other hydrates. The chemical structure of Upadacitinib hemihydrate is designed to interact with specific biological targets, which makes it a promising candidate for the treatment of a variety of diseases.
II. Physical and Chemical Properties
1. **Appearance**: Upadacitinib hemihydrate typically appears as a white to off – white powder. This physical appearance is important for its handling and formulation processes. The powder form allows for easy mixing with other excipients during the production of pharmaceutical dosage forms.
2. **Solubility**: It has a certain solubility profile in different solvents. In aqueous solutions, its solubility may be affected by factors such as pH. Generally, it has limited solubility in pure water, but the solubility can be enhanced by adjusting the pH or by using co – solvents. In organic solvents, its solubility may vary depending on the polarity of the solvent. For example, it may have relatively better solubility in polar organic solvents like ethanol compared to non – polar solvents such as hexane.
3. **Stability**: The stability of Upadacitinib hemihydrate is a crucial factor in its storage and use. It should be stored under appropriate conditions to prevent degradation. Factors such as temperature, humidity, and light can affect its stability. It is usually recommended to store it in a cool, dry place, protected from light. Under normal storage conditions, it can maintain its chemical integrity for a certain period of time.
III. Uses
1. **Treatment of Inflammatory Diseases**: Upadacitinib hemihydrate, through its JAK – inhibiting activity, is mainly used for the treatment of inflammatory diseases. JAK kinases play a key role in the signaling pathways of cytokines, which are involved in the immune response. By inhibiting JAK kinases, Upadacitinib hemihydrate can reduce the production and activity of pro – inflammatory cytokines. This makes it effective in treating diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
2. **Autoimmune Disorders**: In addition to inflammatory diseases, it also shows potential in the treatment of autoimmune disorders. Autoimmune disorders are characterized by an overactive immune system attacking the body’s own tissues. The JAK – inhibiting mechanism of Upadacitinib hemihydrate can help regulate the immune response and reduce the damage caused by the autoimmune reaction. For example, in some cases of systemic lupus erythematosus, it may be used as an adjunctive treatment to control the symptoms and progression of the disease.
IV. Applications in Various Fields
1. **Pharmaceutical Industry**:
In the pharmaceutical industry, Upadacitinib hemihydrate is the active pharmaceutical ingredient (API) for the development of drugs. It is formulated into various dosage forms, such as tablets and capsules, for oral administration. The formulation process needs to consider factors such as the solubility, stability, and bioavailability of Upadacitinib hemihydrate. Pharmaceutical companies conduct extensive research and development to optimize the formulation to ensure the effectiveness and safety of the final drug product. Clinical trials are also carried out to evaluate the efficacy and safety of drugs containing Upadacitinib hemihydrate in different patient populations.
2. **Biomedical Research**:
In biomedical research, Upadacitinib hemihydrate is used as a tool compound to study the role of JAK kinases in biological processes. Researchers can use it to investigate the signaling pathways of cytokines and the immune response. By blocking JAK kinases with Upadacitinib hemihydrate, they can observe the changes in cell function and gene expression. This helps in understanding the pathophysiology of various diseases and developing new therapeutic strategies. For example, in cancer research, the role of JAK – STAT signaling pathway is being investigated, and Upadacitinib hemihydrate can be used to study the impact of JAK inhibition on tumor cell growth and metastasis.
V. Preparation Methods
1. **Synthetic Routes**:
The synthesis of Upadacitinib hemihydrate usually involves a multi – step chemical process. Starting from appropriate starting materials, a series of chemical reactions are carried out, including condensation, cyclization, and functional group modifications. For example, some synthetic routes may start with commercially available aromatic compounds and build the core structure of Upadacitinib through a series of reactions. The reaction conditions, such as temperature, pressure, and reaction time, need to be carefully controlled to ensure high yields and purity of the product.
2. **Purification and Hydration**:
After the synthesis of the anhydrous form of Upadacitinib, purification steps are required to remove impurities. This can be achieved through methods such as crystallization, chromatography, and recrystallization. Once the purified anhydrous Upadacitinib is obtained, it can be converted to the hemihydrate form. This is usually done by exposing the anhydrous compound to a controlled environment with a specific humidity level or by adding a calculated amount of water during a crystallization process. The formation of the hemihydrate form needs to be carefully monitored to ensure the correct stoichiometry of water in the final product.
Send Inquiry